Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
Bloomberg Television · 12:00 · Watch on YouTube
Moderna’s CEO calls the personalized mRNA melanoma vaccine plus Merck’s Keytruda a landmark result: at two years it showed about a 42% improvement over Keytruda alone, a bar three earlier large trials missed, while ar...